Detalhe da pesquisa
1.
Antigen-Specific Antitumor Responses Induced by OX40 Agonist Are Enhanced by the IDO Inhibitor Indoximod.
Cancer Immunol Res
; 6(2): 201-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305519
2.
Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
J Immunother Cancer
; 5(1): 64, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807056